CASTLE BIOSCIENCES INC (CSTL)
Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, Decision Dx DiffDx-Melanoma, DecisonDx-CMSeq, DecisionDx-SCC, DecsionDx-UMSeq, and DecisonDX-PRAME. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
Address
505 S FRIENDSWOOD DRIVE
FRIENDSWOOD, TX 77546
Founded
2007
Number of Employees
610
Website
http://www.castlebiosciences.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)